# Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes

Study · id `cardio:ct-nct04843527` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04843527](<https://clinicaltrials.gov/study/NCT04843527>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04843527

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.

## Technical summary

Registry record NCT04843527. Randomized; no masking; primary purpose other. Start 2021-04-02 (actual); primary completion 2025-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT04843527, source copy `cardio:ctgov-nct04843527-2025-01-30`, retrieved 2026-10-26)
- Started: 2021-04-02 (actual) (ClinicalTrials.gov record NCT04843527, source copy `cardio:ctgov-nct04843527-2025-01-30`, retrieved 2026-10-26)
- Primary completion: 2025-06 (anticipated) (ClinicalTrials.gov record NCT04843527, source copy `cardio:ctgov-nct04843527-2025-01-30`, retrieved 2026-10-26)
- Completion: 2025-06 (anticipated) (ClinicalTrials.gov record NCT04843527, source copy `cardio:ctgov-nct04843527-2025-01-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04843527, source copy `cardio:ctgov-nct04843527-2025-01-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04843527-2025-01-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): FreeStyle Libre System
- Intervention (Device): FreeStyle Libre System plus food app
- Lead sponsor: Abbott Diabetes Care
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Abbott Diabetes Care (`cardio:org-abbott-diabetes-care`)

## Provenance

Content hash: 7a665a4a28e184b3a6c1c6825e75fdd48fef51f8b2a343db29459d4b73ac1d62
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
